UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Power of Full-Time Certified School Librarians in Missouri: Boosting Student Achievement Across Disciplines

School libraries worldwide, 2023-10, Vol.28 (2), p.1-18

2023

Volltextzugriff (PDF)

Learning to read online: the effect of instruction on e-textbook use

Library hi tech, 2019-06, Vol.37 (2), p.289-307

2019

Volltextzugriff (PDF)

An Investigation into Business Education Classroom Pedagogies

Educational research quarterly, 2023-12, Vol.47 (2), p.3-27

2023

Volltextzugriff (PDF)

A Co-Requisite Pathway for Mathematics: Pairing a Developmental Lab with a Gateway Course

Atkins, Charlene

2016

Volltextzugriff (PDF)

An Investigation of Placement Measures and Student Performance in a Co-requisite Mathematics Pathway

Research & teaching in developmental education, 2017-04, Vol.33 (2), p.5-20

2017

Volltextzugriff (PDF)

Supporting Teacher Candidates During COVID-19

Educational Renaissance, 2020-10, Vol.9 (1), p.31-40

2020

Volltextzugriff (PDF)

A Co-Requisite Model for Developmental Mathematics

Educational Renaissance, 2017-03, Vol.5 (1), p.13-25

2017

Volltextzugriff (PDF)

Salvage Ipilimumab and Nivolumab in Patients With Metastatic Renal Cell Carcinoma After Prior Immune Checkpoint Inhibitors

Journal of clinical oncology, 2020-09, Vol.38 (27), p.3088-3094

2020

Volltextzugriff (PDF)

Sensitivity of treatment-free survival to subgroup analyses in patients with advanced melanoma treated with immune checkpoint inhibitors

Melanoma research, 2022-02, Vol.32 (1), p.35-44

2022

Volltextzugriff (PDF)

Treatment-free Survival after Immune Checkpoint Inhibitor Therapy versus Targeted Therapy for Advanced Renal Cell Carcinoma: 42-Month Results of the CheckMate 214 Trial

Clinical cancer research, 2021-12, Vol.27 (24), p.6687-6695

2021

Volltextzugriff (PDF)

Biphasic burrowing in Atlantic hagfish (Myxine limosa)

Journal of experimental biology, 2024-06, Vol.227 (12)

2024

Volltextzugriff (PDF)

Treatment-free survival over extended follow-up of patients with advanced melanoma treated with immune checkpoint inhibitors in CheckMate 067

Journal for immunotherapy of cancer, 2021-11, Vol.9 (11), p.e003743

2021

Volltextzugriff (PDF)

Prognostic factors for patients with advanced renal cell carcinoma (aRCC) in the era of first-line (1L) treatment with immune checkpoint inhibitors (ICIs)

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.4544-4544

2022

Volltextzugriff (PDF)

Treatment-free survival and partitioned survival analysis of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib: 5-year update of CheckMate 214

Journal for immunotherapy of cancer, 2024-07, Vol.12 (7), p.e009495

2024

Volltextzugriff (PDF)

Peptidyl-Prolyl Isomerase ppiB Is Essential for Proteome Homeostasis and Virulence in Burkholderia pseudomallei

Infection and immunity, 2019-10, Vol.87 (10)

2019

Volltextzugriff (PDF)

Sensitivity of treatment-free survival (TFS), a novel outcome, to subgroup analyses of patients (pts) with advanced melanoma (MEL) treated with immune checkpoint inhibitors (ICI)

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.9550-9550

2019

Volltextzugriff (PDF)

Estimating treatment-free survival (TFS) over extended follow-up in patients (pts) with advanced melanoma (MEL) treated with immune-checkpoint inhibitors (ICIs): Five-year follow-up of CheckMate 067

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.10043-10043

2020

Volltextzugriff (PDF)

Ipilimumab plus nivolumab (Ipi/Nivo) as salvage therapy in patients with immunotherapy (IO)-refractory metastatic renal cell carcinoma (mRCC)

Journal of clinical oncology, 2019-03, Vol.37 (7_suppl), p.669-669

2019

Volltextzugriff (PDF)

Treatment-Free Survival after Immune Checkpoint Inhibitor Therapy vs. Targeted Therapy for Advanced Renal Cell Carcinoma: 42-Month Results of the CheckMate 214 Trial

Clinical cancer research, 2021-11, Vol.27 (24), p.6687-6695

2021

Volltextzugriff (PDF)

Glutamine and Antioxidants in the Critically Ill Patient: A Post Hoc Analysis of a Large-Scale Randomized Trial

JPEN. Journal of parenteral and enteral nutrition, 2015-05, Vol.39 (4), p.401-409

2015

Volltextzugriff (PDF)

Black Newspapers as a Tool for Cancer Education in African American Communities

Ethnicity & disease, 2008-01, Vol.18 (4), p.488-495

2008

Volltextzugriff (PDF)

Emily Donelson of Tennessee

Journal of the Early Republic, 2002, Vol.22 (1), p.149-151

Lewis, Charlene Boyer

2002

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(19)
Mit Volltextzugriff
(16)

Publikationsform

Sprache

Englisch
(22)

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Power of Full-Time Certified School Librarians in Missouri: Boosting Student Achievement Across Disciplines

Learning to read online: the effect of instruction on e-textbook use

An Investigation into Business Education Classroom Pedagogies

A Co-Requisite Pathway for Mathematics: Pairing a Developmental Lab with a Gateway Course

An Investigation of Placement Measures and Student Performance in a Co-requisite Mathematics Pathway

Supporting Teacher Candidates During COVID-19

A Co-Requisite Model for Developmental Mathematics

Salvage Ipilimumab and Nivolumab in Patients With Metastatic Renal Cell Carcinoma After Prior Immune Checkpoint Inhibitors

Sensitivity of treatment-free survival to subgroup analyses in patients with advanced melanoma treated with immune checkpoint inhibitors

Treatment-free Survival after Immune Checkpoint Inhibitor Therapy versus Targeted Therapy for Advanced Renal Cell Carcinoma: 42-Month Results of the CheckMate 214 Trial

Biphasic burrowing in Atlantic hagfish (Myxine limosa)

Treatment-free survival over extended follow-up of patients with advanced melanoma treated with immune checkpoint inhibitors in CheckMate 067

Prognostic factors for patients with advanced renal cell carcinoma (aRCC) in the era of first-line (1L) treatment with immune checkpoint inhibitors (ICIs)

Treatment-free survival and partitioned survival analysis of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib: 5-year update of CheckMate 214

Peptidyl-Prolyl Isomerase ppiB Is Essential for Proteome Homeostasis and Virulence in Burkholderia pseudomallei

Sensitivity of treatment-free survival (TFS), a novel outcome, to subgroup analyses of patients (pts) with advanced melanoma (MEL) treated with immune checkpoint inhibitors (ICI)

Estimating treatment-free survival (TFS) over extended follow-up in patients (pts) with advanced melanoma (MEL) treated with immune-checkpoint inhibitors (ICIs): Five-year follow-up of CheckMate 067

Ipilimumab plus nivolumab (Ipi/Nivo) as salvage therapy in patients with immunotherapy (IO)-refractory metastatic renal cell carcinoma (mRCC)

Treatment-Free Survival after Immune Checkpoint Inhibitor Therapy vs. Targeted Therapy for Advanced Renal Cell Carcinoma: 42-Month Results of the CheckMate 214 Trial

Glutamine and Antioxidants in the Critically Ill Patient: A Post Hoc Analysis of a Large-Scale Randomized Trial

Black Newspapers as a Tool for Cancer Education in African American Communities

Emily Donelson of Tennessee

Suchergebnisse filtern